Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies
Clicks: 274
ID: 115318
1998
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
78.5
/100
267 views
218 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Modern chemotherapy for lymphoma and solid tissue malignancy is most frequently administered in a cyclical fashion on an outpatient basis over many months. During this time patients have a significant risk of developing severe neutropenia due to the myelotoxic effects of the treatment regimens; this …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (45 words).
Try re-searching for a better abstract.
| Reference Key |
ej1998theinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bow EJ;; |
| Journal | The Journal of antimicrobial chemotherapy |
| Year | 1998 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
risk
fever / etiology*
neoplasms / immunology*
lymphoma / drug therapy
neoplasms / drug therapy*
antineoplastic agents / adverse effects*
pmid:9688446
doi:10.1093/jac/41.suppl_4.1
e j bow
lymphoma / immunology
neutropenia / etiology*
neutropenia / immunology
opportunistic infections* / immunology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.